Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: Empiric therapy for febrile, neutropenic bone marrow transplant patients

Hillard M. Lazarus, Richard J. Creger, Rasim Gucalp, Robert M. Fox, Niculae Ciobanu, Penelope S. Carlisle, Brenda W. Cooper, Michael R. Jacobs

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: Empiric therapy for febrile, neutropenic bone marrow transplant patients'. Together they form a unique fingerprint.

Medicine & Life Sciences